Industry Research Reports

Home > Reports > Medical Devices & Consumables > Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-01-08

Pages: 108 Pages

Report ld: 3009515

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Infectious Diseases Molecular Diagnostics Kit Market Size(US$)

CAGR 2024-2030

7.5%

Market Size,2030

USD 28,820

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 18,670 million

Market Forecast in 2030(Value)

US$ 28,820 million

CAGR

7.5%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.

The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 31410 million in 2023 and is forecast to a readjusted size of US$ 28820 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others

Segment by Application

Hospital
Third-party Testing Agency
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Infectious Diseases Molecular Diagnostics Kit, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Diseases Molecular Diagnostics Kit by region & country, by Type, and by Application.

The Infectious Diseases Molecular Diagnostics Kit market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases Molecular Diagnostics Kit.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Infectious Diseases Molecular Diagnostics Kit manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Infectious Diseases Molecular Diagnostics Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Infectious Diseases Molecular Diagnostics Kit in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Infectious Diseases Molecular Diagnostics Kit Product Introduction

1.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast

1.3 Infectious Diseases Molecular Diagnostics Kit Market Trends & Drivers

1.3.1 Infectious Diseases Molecular Diagnostics Kit Industry Trends

1.3.2 Infectious Diseases Molecular Diagnostics Kit Market Drivers & Opportunity

1.3.3 Infectious Diseases Molecular Diagnostics Kit Market Challenges

1.3.4 Infectious Diseases Molecular Diagnostics Kit Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Infectious Diseases Molecular Diagnostics Kit Players Revenue Ranking (2023)

2.2 Global Infectious Diseases Molecular Diagnostics Kit Revenue by Company (2019-2024)

2.3 Key Companies Infectious Diseases Molecular Diagnostics Kit Manufacturing Base Distribution and Headquarters

2.4 Key Companies Infectious Diseases Molecular Diagnostics Kit Product Offered

2.5 Key Companies Time to Begin Mass Production of Infectious Diseases Molecular Diagnostics Kit

2.6 Infectious Diseases Molecular Diagnostics Kit Market Competitive Analysis

2.6.1 Infectious Diseases Molecular Diagnostics Kit Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Infectious Diseases Molecular Diagnostics Kit Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics Kit as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Polymerase Chain Reaction PCR

3.1.2 Molecular Hybridization

3.1.3 Biochip

3.1.4 Others

3.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Type

3.2.1 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Value, by Type (2019-2030)

3.2.3 Global Infectious Diseases Molecular Diagnostics Kit Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Third-party Testing Agency

4.1.3 Others

4.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Application

4.2.1 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Value, by Application (2019-2030)

4.2.3 Global Infectious Diseases Molecular Diagnostics Kit Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region

5.1.1 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region (2019-2024)

5.1.3 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region (2025-2030)

5.1.4 Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

5.2.2 North America Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

5.3.2 Europe Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

5.4.2 Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

5.5.2 South America Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

5.6.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Infectious Diseases Molecular Diagnostics Kit Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Infectious Diseases Molecular Diagnostics Kit Sales Value

6.3 United States

6.3.1 United States Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

6.3.2 United States Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Infectious Diseases Molecular Diagnostics Kit Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

6.4.2 Europe Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Infectious Diseases Molecular Diagnostics Kit Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

6.5.2 China Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

6.5.3 China Infectious Diseases Molecular Diagnostics Kit Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

6.6.2 Japan Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Infectious Diseases Molecular Diagnostics Kit Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

6.7.2 South Korea Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Infectious Diseases Molecular Diagnostics Kit Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

6.8.2 Southeast Asia Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Infectious Diseases Molecular Diagnostics Kit Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019-2030

6.9.2 India Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

6.9.3 India Infectious Diseases Molecular Diagnostics Kit Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche

7.1.1 Roche Profile

7.1.2 Roche Main Business

7.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.1.4 Roche Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.1.5 Roche Recent Developments

7.2 Qiagen

7.2.1 Qiagen Profile

7.2.2 Qiagen Main Business

7.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.2.4 Qiagen Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.2.5 Qiagen Recent Developments

7.3 Illumina

7.3.1 Illumina Profile

7.3.2 Illumina Main Business

7.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.3.4 Illumina Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.3.5 Abbott Recent Developments

7.4 Abbott

7.4.1 Abbott Profile

7.4.2 Abbott Main Business

7.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.4.4 Abbott Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.4.5 Abbott Recent Developments

7.5 Hologic

7.5.1 Hologic Profile

7.5.2 Hologic Main Business

7.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.5.4 Hologic Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.5.5 Hologic Recent Developments

7.6 BioMerieux

7.6.1 BioMerieux Profile

7.6.2 BioMerieux Main Business

7.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.6.4 BioMerieux Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.6.5 BioMerieux Recent Developments

7.7 Danaher (Cepheid)

7.7.1 Danaher (Cepheid) Profile

7.7.2 Danaher (Cepheid) Main Business

7.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.7.4 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.7.5 Danaher (Cepheid) Recent Developments

7.8 Myriad Genetics

7.8.1 Myriad Genetics Profile

7.8.2 Myriad Genetics Main Business

7.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.8.4 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.8.5 Myriad Genetics Recent Developments

7.9 DAAN Gene

7.9.1 DAAN Gene Profile

7.9.2 DAAN Gene Main Business

7.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.9.4 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.9.5 DAAN Gene Recent Developments

7.10 Agilent

7.10.1 Agilent Profile

7.10.2 Agilent Main Business

7.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.10.4 Agilent Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.10.5 Agilent Recent Developments

7.11 Genomic Health

7.11.1 Genomic Health Profile

7.11.2 Genomic Health Main Business

7.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.11.4 Genomic Health Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.11.5 Genomic Health Recent Developments

7.12 BD

7.12.1 BD Profile

7.12.2 BD Main Business

7.12.3 BD Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.12.4 BD Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.12.5 BD Recent Developments

7.13 Foundation Medicine

7.13.1 Foundation Medicine Profile

7.13.2 Foundation Medicine Main Business

7.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

7.13.4 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Revenue (US$ Million) & (2019-2024)

7.13.5 Foundation Medicine Recent Developments

8 Industry Chain Analysis

8.1 Infectious Diseases Molecular Diagnostics Kit Industrial Chain

8.2 Infectious Diseases Molecular Diagnostics Kit Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Infectious Diseases Molecular Diagnostics Kit Sales Model

8.5.2 Sales Channel

8.5.3 Infectious Diseases Molecular Diagnostics Kit Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Infectious Diseases Molecular Diagnostics Kit Market Trends

Table 2. Infectious Diseases Molecular Diagnostics Kit Market Drivers & Opportunity

Table 3. Infectious Diseases Molecular Diagnostics Kit Market Challenges

Table 4. Infectious Diseases Molecular Diagnostics Kit Market Restraints

Table 5. Global Infectious Diseases Molecular Diagnostics Kit Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Infectious Diseases Molecular Diagnostics Kit Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Infectious Diseases Molecular Diagnostics Kit Product Type

Table 9. Key Companies Time to Begin Mass Production of Infectious Diseases Molecular Diagnostics Kit

Table 10. Global Infectious Diseases Molecular Diagnostics Kit Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases Molecular Diagnostics Kit as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Infectious Diseases Molecular Diagnostics Kit Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region (2019-2024) & (%)

Table 27. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Infectious Diseases Molecular Diagnostics Kit Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Infectious Diseases Molecular Diagnostics Kit Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Infectious Diseases Molecular Diagnostics Kit Sales Value, (2025-2030) & (US$ Million)

Table 31. Roche Basic Information List

Table 32. Roche Description and Business Overview

Table 33. Roche Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 34. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Roche (2019-2024)

Table 35. Roche Recent Developments

Table 36. Qiagen Basic Information List

Table 37. Qiagen Description and Business Overview

Table 38. Qiagen Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 39. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Qiagen (2019-2024)

Table 40. Qiagen Recent Developments

Table 41. Illumina Basic Information List

Table 42. Illumina Description and Business Overview

Table 43. Illumina Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 44. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Illumina (2019-2024)

Table 45. Illumina Recent Developments

Table 46. Abbott Basic Information List

Table 47. Abbott Description and Business Overview

Table 48. Abbott Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 49. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Abbott (2019-2024)

Table 50. Abbott Recent Developments

Table 51. Hologic Basic Information List

Table 52. Hologic Description and Business Overview

Table 53. Hologic Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 54. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Hologic (2019-2024)

Table 55. Hologic Recent Developments

Table 56. BioMerieux Basic Information List

Table 57. BioMerieux Description and Business Overview

Table 58. BioMerieux Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 59. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of BioMerieux (2019-2024)

Table 60. BioMerieux Recent Developments

Table 61. Danaher (Cepheid) Basic Information List

Table 62. Danaher (Cepheid) Description and Business Overview

Table 63. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 64. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Danaher (Cepheid) (2019-2024)

Table 65. Danaher (Cepheid) Recent Developments

Table 66. Myriad Genetics Basic Information List

Table 67. Myriad Genetics Description and Business Overview

Table 68. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 69. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Myriad Genetics (2019-2024)

Table 70. Myriad Genetics Recent Developments

Table 71. DAAN Gene Basic Information List

Table 72. DAAN Gene Description and Business Overview

Table 73. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 74. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of DAAN Gene (2019-2024)

Table 75. DAAN Gene Recent Developments

Table 76. Agilent Basic Information List

Table 77. Agilent Description and Business Overview

Table 78. Agilent Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 79. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Agilent (2019-2024)

Table 80. Agilent Recent Developments

Table 81. Genomic Health Basic Information List

Table 82. Genomic Health Description and Business Overview

Table 83. Genomic Health Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 84. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Genomic Health (2019-2024)

Table 85. Genomic Health Recent Developments

Table 86. BD Basic Information List

Table 87. BD Description and Business Overview

Table 88. BD Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 89. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of BD (2019-2024)

Table 90. BD Recent Developments

Table 91. Foundation Medicine Basic Information List

Table 92. Foundation Medicine Description and Business Overview

Table 93. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Products, Services and Solutions

Table 94. Revenue (US$ Million) in Infectious Diseases Molecular Diagnostics Kit Business of Foundation Medicine (2019-2024)

Table 95. Foundation Medicine Recent Developments

Table 96. Key Raw Materials Lists

Table 97. Raw Materials Key Suppliers Lists

Table 98. Infectious Diseases Molecular Diagnostics Kit Downstream Customers

Table 99. Infectious Diseases Molecular Diagnostics Kit Distributors List

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Infectious Diseases Molecular Diagnostics Kit Product Picture

Figure 2. Global Infectious Diseases Molecular Diagnostics Kit Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Infectious Diseases Molecular Diagnostics Kit Sales Value (2019-2030) & (US$ Million)

Figure 4. Infectious Diseases Molecular Diagnostics Kit Report Years Considered

Figure 5. Global Infectious Diseases Molecular Diagnostics Kit Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Diseases Molecular Diagnostics Kit Revenue in 2023

Figure 7. Infectious Diseases Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Polymerase Chain Reaction PCR Picture

Figure 9. Molecular Hybridization Picture

Figure 10. Biochip Picture

Figure 11. Others Picture

Figure 12. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Infectious Diseases Molecular Diagnostics Kit Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Hospital

Figure 15. Product Picture of Third-party Testing Agency

Figure 16. Product Picture of Others

Figure 17. Global Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Infectious Diseases Molecular Diagnostics Kit Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America Infectious Diseases Molecular Diagnostics Kit Sales Value (2019-2030) & (US$ Million)

Figure 20. North America Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe Infectious Diseases Molecular Diagnostics Kit Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

Figure 25. South America Infectious Diseases Molecular Diagnostics Kit Sales Value (2019-2030) & (US$ Million)

Figure 26. South America Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions Infectious Diseases Molecular Diagnostics Kit Sales Value (%), (2019-2030)

Figure 30. United States Infectious Diseases Molecular Diagnostics Kit Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

Figure 32. United States Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe Infectious Diseases Molecular Diagnostics Kit Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (%), 2023 VS 2030

Figure 36. China Infectious Diseases Molecular Diagnostics Kit Sales Value, (2019-2030) & (US$ Million)

Figure 37. China Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

Figure 38. China Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan Infectious Diseases Molecular Diagnostics Kit Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea Infectious Diseases Molecular Diagnostics Kit Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (%), 2023 VS 2030

Figure 48. India Infectious Diseases Molecular Diagnostics Kit Sales Value, (2019-2030) & (US$ Million)

Figure 49. India Infectious Diseases Molecular Diagnostics Kit Sales Value by Type (%), 2023 VS 2030

Figure 50. India Infectious Diseases Molecular Diagnostics Kit Sales Value by Application (%), 2023 VS 2030

Figure 51. Infectious Diseases Molecular Diagnostics Kit Industrial Chain

Figure 52. Infectious Diseases Molecular Diagnostics Kit Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Infectious Diseases Molecular Diagnostics Kit in 2024? zhanKai

The global market size of Infectious Diseases Molecular Diagnostics Kit in 2024 was 18670 Million USD.

What is the annual compound growth rate of the global Infectious Diseases Molecular Diagnostics Kit market size from 2024 to 2030? shouQi

Which companies rank high in the global Infectious Diseases Molecular Diagnostics Kit market? shouQi

What was the global market size of Infectious Diseases Molecular Diagnostics Kit in 2030? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 21280 million in 2025 and is projected to reach US$ 35060 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 115
USD 3950.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2026
The global Infectious Diseases Molecular Diagnostics Kit market was valued at US$ 21280 million in 2025 and is anticipated to reach US$ 35060 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 118
USD 2900.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Infectious Diseases Molecular Diagnostics Kit market is projected to grow from US$ 19930 million in 2024 to US$ 32840 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 142
USD 4900.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025
The global market for Infectious Diseases Molecular Diagnostics Kit was valued at US$ 19930 million in the year 2024 and is projected to reach a revised size of US$ 32840 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-01-16
Pages: 82
USD 2900.00
(Single User License)
Infectious Diseases Molecular Diagnostics Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 19930 million in 2024 and is forecast to a readjusted size of US$ 32840 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 108
USD 3950.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Insights, Forecast to 2030
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published Date: 2024-04-12
Pages: 110
USD 4900.00
(Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2024
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published Date: 2024-01-12
Pages: 86
USD 2900.00
(Single User License)

Infectious Diseases Molecular Diagnostics Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 21280 million in 2025 and is projected to reach US$ 35060 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 115
USD 3950.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2026
The global Infectious Diseases Molecular Diagnostics Kit market was valued at US$ 21280 million in 2025 and is anticipated to reach US$ 35060 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-04-17
Pages: 118
USD 2900.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Infectious Diseases Molecular Diagnostics Kit market is projected to grow from US$ 19930 million in 2024 to US$ 32840 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 142
USD 4900.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025
The global market for Infectious Diseases Molecular Diagnostics Kit was valued at US$ 19930 million in the year 2024 and is projected to reach a revised size of US$ 32840 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-01-16
Pages: 82
USD 2900.00 (Single User License)
Infectious Diseases Molecular Diagnostics Kit- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Infectious Diseases Molecular Diagnostics Kit was estimated to be worth US$ 19930 million in 2024 and is forecast to a readjusted size of US$ 32840 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 108
USD 3950.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Insights, Forecast to 2030
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published: 2024-04-12
Pages: 110
USD 4900.00 (Single User License)
Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2024
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
Published: 2024-01-12
Pages: 86
USD 2900.00 (Single User License)